Comparative Pharmacology
Head-to-head clinical analysis: ANTHELIOS 20 versus SHADE UVAGUARD.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ANTHELIOS 20 versus SHADE UVAGUARD.
ANTHELIOS 20 vs SHADE UVAGUARD
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Anthelios 20 is a sunscreen containing octocrylene, homosalate, octisalate, oxybenzone, and avobenzone. It provides broad-spectrum UVA/UVB protection by absorbing, reflecting, or scattering ultraviolet radiation. The active ingredients, particularly avobenzone and oxybenzone, absorb UV radiation and dissipate it as heat, preventing direct DNA damage and reducing the risk of skin cancers and photoaging.
SHADE UVAGUARD is a sunscreen product containing chemical UV filters such as avobenzone, octinoxate, and oxybenzone. These organic compounds absorb UV radiation and convert it into heat, preventing DNA damage. Avobenzone absorbs UVA rays, while octinoxate and oxybenzone absorb UVB rays. The combination provides broad-spectrum protection.
Apply to all exposed skin 15 minutes before sun exposure; reapply every 2 hours or after swimming/sweating. Not for oral administration.
Topical application of 2 mg/cm² to all sun-exposed areas 15 minutes before sun exposure; reapply every 2 hours and after swimming or sweating.
None Documented
None Documented
Terminal half-life is approximately 20 hours for the active sunscreen agents, supporting once-daily application with sustained protection.
Not applicable (topical, non-systemic); if absorbed, estimated <1 hour.
Primarily fecal excretion (90-95%) as unchanged drug, with less than 5% renal excretion of metabolites.
Renal: <1% unchanged; Biliary/fecal: negligible; Primarily remains on skin surface and is removed via washing or sloughing.
Category C
Category C
Sunscreen
Sunscreen